Download presentation
Presentation is loading. Please wait.
Published byJodie Jackson Modified over 9 years ago
1
Adrenalectomy in a Golden Retriever Betty Lobanov Jan 29 th 2014
2
Signalment & History 10 year old female spayed Golden Retriever Presented to CUHA Soft Tissue Surgery service for adrenalectomy Presenting complaints to rDVM 2 months prior Polyphagia Polyuria Alopecia Muscle atrophy
3
Problem List Alopecia ▫Primary dermatologic, Endocrine, Immune mediated Polyphagia ▫Endocrine Polyuria ▫Endocrine, Renal disease, Hypercalcemia, Diuresis, Pyelonephritis, Psychogenic Muscle atrophy ▫Degenerative, Endocrine, Nutritional, Immune mediated, Neurologic, Orthopedic
4
Diagnostics Senior wellness exam April 2013 ▫CBC: mild lymphopenia ▫Chem: ↑ cholesterol, ↑ triglycerides ▫T4: WNL ▫Urinalysis: 2+ proteinuria ▫USG 1.016 USG & urine protein re-checks recommended ▫3+ proteinuria, USG 1.036 Proteinuria still persisted recommended urine protein:creatinine (UPC), blood pressure, urine culture/sensitivity ▫UPC 1.3 (normal < 0.5) ▫Culture/Sensitivity: No growth ▫Monitor & re-check in 4 months
5
Diagnostics Re-check August 2013 ▫CBC: lymphopenia, eosinopenia ▫Chem: ↑ cholesterol, ↑ triglycerides ▫Urine culture/sensitivity: E.coli organisms Amoxicillin 400mg Re-check 5-7 days after termination of therapy no growth
6
Problem List Alopecia ▫Primary dermatologic, Endocrine, Immune mediated Polyphagia ▫Endocrine Polyuria ▫Endocrine, Renal disease, Hypercalcemia, Diuresis, Pyelonephritis, Psychogenic Muscle atrophy ▫Degenerative, Endocrine, Nutritional, Immune mediated, Neurologic, Orthopedic
7
But wait, there’s more… Dermatologic punch biopsy 7/12/13 Calcinosis cutis Abdominal ultrasound 7/30/13 adrenal mass ACTH stimulation test ▫Screening test ▫Confirmatory test ▫Evaluates ability of adrenal gland to secrete cortisol after maximal stimulation ▫Protocol serum cortisol collected for baseline and 1 hour after administering 0.25 mg synthetic ACTH IM serum cortisol collected for baseline and 2 hours after administering 2.2 U/kg ACTH gel IM
8
Hyperadrenocorticism [HAC] Time vs. Cortisol
9
Patient’s ACTH stim consistent with Cushing’s (hyperadrenocorticism) ▫Pre 5.0ug/dL (ref 1.8-4) ▫Post > 50ug/dL (ref 6-16) Low Dose Dexamethasone Suppression Test (LDDS) ▫Differentiating test ▫Pre 3.8ug/dL ▫Post 4hr: 1.5ug/dL (healthy dog < 1ug/dL) ▫Post 8hr: 2.3ug/dL ▫Protocol Baseline blood sample for cortisol Inject 0.01 mg/kg dexamethasone obtain blood sample at 4 & 8hr
10
LDDS Test Time vs. Cortisol
11
Medical management: Trilostane ▫PDH, ADH ▫Competitive inhibition of steroid synthesis 3β-hydroxysteroid dehydrogenase ▫Daily doses needed ▫Cats, Dogs, Birds Re-check cortisol levels post initiating Trilostane ▫ACTH stim Pre 1.9ug/dL (ref 1.8-4) Post 2.4ug/dL (ref 6-16) ▫ Trilostane decreased from 60mg to 30mg
12
Hyperadrenocorticism (Cushing’s) 3 types –treated differently and different prognosis Pituitary dependent hyperadrenocorticism (PDH) ▫85%-90%; overproduction ACTH ▫Can live normal lives for many years with medical management (controlling adrenal gland) ▫15% neurological signs Macroadenomas > 1cm in diameter Microadenomas < 1cm in diameter Adrenal dependent hyperadrencocorticism (ADH) ▫Functional tumor on the adrenal cortex ▫Adenoma or carcinoma ▫Benign surgical removal, curative ▫Malignant surgical removal may help but prognosis guarded- poor Iatrogenic ▫Excessive administration of an oral or injectable steroid
13
Hyperadrenocorticism (Cushing’s)
14
Adrenal Architecture & Products
15
Back to our visit 9/24/13 CUHA Soft Tissue Surgery Physical exam ▫T: 101.8°F P: 108bpm R: 32bpm ▫23.5kg ▫BAR ▫Bilateral alopecia around the elbows ▫Hindlimb muscle atrophy ▫Healing sebaceous cyst on right hindlimb
16
Pre-op Diagnostics CBC Chemistry panel Abdominal ultrasound Thoracic radiograph RESULTS: CBC: no significant findings Chem: ↑ cholesterol 557mg/dL (ref 138-332mg/dL) ↑ triglycerides 314mg/dL (ref 22-125mg/dL) Abdominal U/S: caudal pole of left adrenal gland hyperechoic mass; right adrenal gland normal Thoracic radiographs: no evidence of metastases
18
Surgical Approaches Ventral midline ▫Dorsal recumbency, surgically prepped ▫Xiphoid-pubis incision
19
Surgical Approaches Paralumbar ▫Lateral recumbency, surgically prepped ▫Lateral vertebral process-within 3-4cm of ventral midline incision (caudal to 13 th rib)
20
Surgical Approaches Laparoscopic ▫Lateral/near-lateral with affected gland up, surgically prepped ▫Endoscopic tower directly opposite surgeon facing patient’s back ▫3 or 4 port technique; Instrument ports are placed in a triangulating pattern around the location of the adrenal gland
21
ApproachProsCons Ventral midline-Standard approach -Enhanced visualization for exploratory/metastatic evaluation -Exposure of both adrenal glands -Dehiscence -Exposure & dissection may be difficult in large dogs Paralumbar-Better access to adrenal gland -Minimal dissection and damage to pancreas -Limited metastatic evaluation -Dehiscence Laparoscopic-Minimally invasive -Decreased pain -Less risk of dehiscence, wound infection -Shorter hospitalization -Ability to address complications compromised - Profuse hemorrhage possible
22
Exposure via Paralumbar
24
9/25/13 Surgery Day Exploratory laparotomy & Left adrenalectomy ▫Xiphoid-pubis incision ▫Abdominal exploration: unremarkable ▫Mass identified & dissected Right angle forceps, tenotomy scissors, bipolar electrocautery (hemostasis) ▫Phrenicoabdominal vein ligated with hemoclips ▫2 layer closure ▫Skin staples & Tegaderm patch Intra-op Dexamethasone IV
25
Post-operative Care 9/25/13 ▫Dexamethasone IV ▫Plasmalyte fluids IV ▫Fentanyl CRI ▫Fragmin SQ 9/26/13 ▫Plasmalyte fluids IV ▫Fentanyl patch ▫ACTH stim Pre 0.25ug/dL (ref 1.8-4) Post 3.74ug/dL (ref 6-16) ▫Discontinued Fragmin 9/27/13 ▫Discontinued Hetastarch & Fentanyl CRI ▫Prednisone 5mg PO ▫Omeprazole 20mg PO ▫PT/PTT Discharged 9/28/13
26
Complications Addisonian crisis ▫Hypoadrenocorticism ▫Lack of aldosterone Hemorrhage Fluid & electrolyte imbalances Pulmonary thromboembolism Delayed wound healing
27
Histopathology ◦ NORMAL ADRENAL MASS Dx: Locally extensive cortical adenoma
28
Adrenal Neoplasia Adrenocortical ▫Adrenal carcinoma ▫Adrenal adenoma Pheochromocytoma: catecholamine secreting tumors arising from medullary tissue Clinical signs due to nonfunctional tumors are caused by local invasion of the tumor into surrounding tissue, distant metastases, or both Functional tumors secrete excessive amounts of cortisol, which inhibits pituitary ACTH secretion and causes atrophy of the contralateral adrenal gland
29
Adrenal Neoplasia Adrenocortical adenomas and carcinomas appear to occur with equal frequency Usually unilateral Complications ▫Adrenal insufficiency ▫Pulmonary thromboembolism ▫Pancreatitis Post op 2.5-11% (Schwartz 2008) Increase in manipulation due to invasive tumor ▫Recurrence Clinical signs related to HAC within 3 years ~ 33% (Axlund 2003)
30
Cost Visit + Specialty exam = $123 Diagnostics = $579 Surgery & Anesthesia = $1,113 ▫Adrenalectomy = $462 ▫Isoflurane = $206 Hospitalization = $1,219 ▫ICU Maintenance = $165 + $165 ▫Cosynotropin $62 ▫ACTH stim = $29.48 ▫PT/PTT = $80 ▫Fragmin = $110 + $216 ▫BP monitoring = 3 x $32 = $96 ▫Gaslyte monitoring = $64 + $96 + $64 ▫PCV/TP = 2 x $36 Total: $3,780.68
31
Patient follow-up 10/8/13 re-check at CUHA Soft Tissue Surgery Service ▫Ravenous appetite diminished ▫Discontinued Omeprazole and Fentanyl patch ▫Taking Prednisone 10/23/13 ▫rDVM call: doing well clinically, taking Prednisone EOD ▫ACTH stim Pre 3.4ug/dL (ref 1.8-4) Post 14.2ug/dL (ref 6-16)
32
Thank you to my advisors: Dr. Harvey Dr. Jay
33
Resources Axlund TW, Behrend EN: Surgical Treatment of Canine Hyperadrenocorticism, Vol. 25, No. 5, May 2003 Feldman EC, Nelson RW: Hyperadrenocorticism (Cushing’s syndrome), in Feldman BF, Nelson RW (eds): Canine and Feline Endocrinology and Reproduction, ed 2. Philadelphia, WB Saunders, 1996, pp 187-265 Fossum, Theresa. Small Animal Surgery, 3 rd edition. St.Louis: Mosby Inc., 2007 http://www.vsso.org/Adrenal_Cortical_Tumor.html Massari F, Nicoli S, et al. Adrenalectomy in dogs with adrenal gland tumors: 52 cases (2002-2008). J Am Vet Med Assoc 2011; 239:216-221 Pelaez MJ, Bouvy BM, Dupre GP: Laparoscopic adrenalectomy for treatment of unilateral adrenocortical carcinomas: Techniques, complications and results in seven dogs. Vet Surg 2008;37:444-453 Schwartz P, Kovak JR, Koprowski A, et al. Evaluation of prognostic factors in the surgical treatment of adrenal gland tumors in dogs: 41 cases (1999- 2005). J Am Vet Med Assoc 2008; 232:77-84
34
Questions?
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.